Molecular Imaging in Nanotechnology and Theranostics

被引:25
|
作者
Andreou, Chrysafis [1 ]
Pal, Suchetan [1 ]
Rotter, Lara [2 ]
Yang, Jiang [1 ]
Kircher, Moritz F. [1 ,3 ,4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Ctr Mol Imaging & Nanotechnol CMINT, New York, NY 10065 USA
[4] Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA
关键词
Nanoparticles; Imaging; Theranostic; WMIS; MINT; IRON-OXIDE NANOPARTICLES; POSITRON-EMISSION-TOMOGRAPHY; SEMICONDUCTING POLYMER NANOPARTICLES; COPPER SULFIDE NANOPARTICLES; UP-CONVERSION NANOPARTICLES; MESOPOROUS SILICA NANOPARTICLES; RAMAN-SCATTERING NANOPARTICLES; TARGETED PHOTOTHERMAL THERAPY; PHOTOACOUSTIC CONTRAST AGENT; EMBEDDED GOLD NANOPARTICLES;
D O I
10.1007/s11307-017-1056-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The fields of biomedical nanotechnology and theranostics have enjoyed exponential growth in recent years. The "Molecular Imaging in Nanotechnology and Theranostics" (MINT) Interest Group of the World Molecular Imaging Society (WMIS) was created in order to provide a more organized and focused forum on these topics within the WMIS and at the World Molecular Imaging Conference (WMIC). The interest group was founded in 2015 and was officially inaugurated during the 2016 WMIC. The overarching goal of MINT is to bring together the many scientists who work on molecular imaging approaches using nanotechnology and those that work on theranostic agents. MINT therefore represents scientists, labs, and institutes that are very diverse in their scientific backgrounds and areas of expertise, reflecting the wide array of materials and approaches that drive these fields. In this short review, we attempt to provide a condensed overview over some of the key areas covered by MINT. Given the breadth of the fields and the given space constraints, we have limited the coverage to the realm of nanoconstructs, although theranostics is certainly not limited to this domain. We will also focus only on the most recent developments of the last 3-5 years, in order to provide the reader with an intuition of what is "in the pipeline" and has potential for clinical translation in the near future.
引用
收藏
页码:363 / 372
页数:10
相关论文
共 50 条
  • [1] Molecular Imaging in Nanotechnology and Theranostics
    Chrysafis Andreou
    Suchetan Pal
    Lara Rotter
    Jiang Yang
    Moritz F. Kircher
    [J]. Molecular Imaging and Biology, 2017, 19 : 363 - 372
  • [2] Molecular imaging for theranostics
    Oyen, W. J. G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 118 : S80 - S80
  • [3] Molecular imaging and theranostics
    Sandach, Patrick
    Rischpler, Christoph
    Herrmann, Ken
    [J]. ONKOLOGE, 2020, 26 (01): : 14 - 21
  • [4] Editorial for Molecular Imaging and Theranostics
    Wei Lu
    [J]. Acta Pharmaceutica Sinica B, 2018, 8 (03) : 318 - 319
  • [5] Molecular imaging for better theranostics
    Dawei Jiang
    Weijun Wei
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3799 - 3801
  • [6] Molecular imaging for better theranostics
    Jiang, Dawei
    Wei, Weijun
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (13) : 3799 - 3801
  • [7] Editorial for Molecular Imaging and Theranostics
    Lu, Wei
    [J]. ACTA PHARMACEUTICA SINICA B, 2018, 8 (03) : 318 - 319
  • [8] Nanotechnology & Molecular Imaging
    Xing, L.
    Pratx, G.
    Chang, S.
    Pogue, B.
    [J]. MEDICAL PHYSICS, 2013, 40 (06)
  • [9] Nanotechnology for molecular imaging
    Lanza, G
    [J]. MEDICAL PHYSICS, 2005, 32 (06) : 2130 - 2130
  • [10] Molecular Theranostics: A Primer for the Imaging Professional
    Lee, Daniel Y.
    Li, King C. P.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 197 (02) : 318 - 324